China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

SHE:000999 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	7,905	5,017	6,771	3,150	3,065	3,824
Trading Asset Securities	2,648	1,677	1,456	-	1,219	200.18
Cash & Short-Term Investments	10,553	6,694	8,227	3,150	4,284	4,024
Cash Growth	19.52%	-18.63%	161.19%	-26.48%	6.45%	30.18%
Accounts Receivable	10,885	8,890	7,946	5,644	5,419	4,807
Other Receivables	294.54	48.29	56.56	14.02	79.28	49.05
Receivables	11,180	8,938	8,003	5,658	5,498	4,856
Inventory	6,710	4,933	5,112	2,499	2,369	1,762
Other Current Assets	1,102	1,311	1,180	681.97	527.57	283.32
Total Current Assets	29,545	21,876	22,522	11,988	12,679	10,925
Property, Plant & Equipment	10,134	6,604	6,614	4,816	4,263	3,767
Long-Term Investments	2,622	1,203	643.12	2,913	238.69	176.35
Goodwill	7,713	5,124	5,124	3,995	4,060	4,105
Other Intangible Assets	3,992	3,378	3,457	2,369	2,297	2,178
Long-Term Deferred Tax Assets	640.06	643.3	626.81	324.5	242.1	150.3
Long-Term Deferred Charges	2,356	897.04	788.34	509.29	467.08	522.68
Other Long-Term Assets	844.25	356.6	373.28	207.33	295.37	185.78
Total Assets	57,846	40,082	40,148	27,123	24,542	22,010
Accounts Payable	4,319	3,149	3,097	1,795	1,499	1,118
Accrued Expenses	1,235	4,868	4,569	3,666	3,215	3,547
Short-Term Debt	2,471	855.57	885.65	168.5	90.04	25
Current Portion of Long-Term Debt	1,015	81.17	93.42	10.76	-	-
Current Portion of Leases	-	78.51	78.6	50.12	45.47	-
Current Income Taxes Payable	577.98	374.34	254.47	110.6	168.15	181.61
Current Unearned Revenue	1,528	1,861	1,650	1,012	1,476	980.14
Other Current Liabilities	9,056	2,338	2,318	1,859	1,453	1,444
Total Current Liabilities	20,202	13,605	12,947	8,673	7,947	7,295
Long-Term Debt	1,039	177.94	1,821	50.22	7.97	-
Long-Term Leases	135.44	91.95	119.51	105.82	88.71	-
Long-Term Unearned Revenue	631.15	449.16	455.5	423.19	395.13	346.4
Long-Term Deferred Tax Liabilities	341.92	343.29	340.79	217.75	198.88	195.42
Other Long-Term Liabilities	157.52	157.99	202.88	36.8	40.19	113.81
Total Liabilities	22,508	14,826	15,887	9,589	8,767	7,951
Common Stock	1,284	1,284	988.18	988.35	978.9	978.9
Additional Paid-In Capital	1,868	1,863	1,878	1,797	1,644	1,636
Retained Earnings	18,033	16,763	16,162	14,297	12,690	11,117
Treasury Stock	-70.74	-70.74	-131.98	-143.57	-	-
Comprehensive Income & Other	63.47	63.17	71.26	70.59	0.22	-4.96
Total Common Equity	21,178	19,903	18,967	17,010	15,313	13,727
Minority Interest	14,161	5,353	5,295	523.78	461.28	331.95
Shareholders' Equity	35,339	25,256	24,262	17,533	15,774	14,059
Total Liabilities & Equity	57,846	40,082	40,148	27,123	24,542	22,010
Total Debt	4,661	1,285	2,998	385.42	232.18	25
Net Cash (Debt)	5,893	5,409	5,229	2,764	4,052	3,999
Net Cash Growth	0.92%	3.45%	89.15%	-31.78%	1.31%	84.68%
Net Cash Per Share	4.59	4.22	4.09	2.15	3.18	3.14
Filing Date Shares Outstanding	1,284	1,284	1,285	1,285	1,273	1,273
Total Common Shares Outstanding	1,284	1,284	1,285	1,285	1,273	1,273
Working Capital	9,343	8,270	9,575	3,316	4,732	3,630
Book Value Per Share	16.49	15.50	14.76	13.24	12.03	10.79
Tangible Book Value	9,473	11,401	10,387	10,645	8,956	7,445
Tangible Book Value Per Share	7.38	8.88	8.09	8.29	7.04	5.85
Buildings	-	5,492	5,122	3,459	3,419	3,170
Machinery	-	4,913	4,544	3,621	3,361	3,053
Construction In Progress	-	306.72	537.8	946.09	407.7	287.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.